Name | (4Z)-4-[(2E)-3-(2-Chlorophenyl)-2-propen-1-ylidene]-1-phenyl-3,5-pyrazolidinedione |
---|---|
Synonyms |
(4Z)-4-[(2E)-3-(2-Chlorophenyl)-2-propen-1-ylidene]-1-phenyl-3,5-pyrazolidinedione
3,5-Pyrazolidinedione, 4-[(2E)-3-(2-chlorophenyl)-2-propen-1-ylidene]-1-phenyl-, (4Z)- |
Description | CPYPP is a small-molecule inhibitor of the Rac activator DOCK2 with IC50 of 22.8 uM (DOCK2DHR-2-mediated Rac GEF activity), inhibits DOCK2-Rac1 interaction; binds to DOCK2 DHR-2 domain in a reversible manner and inhibited its catalytic activity in vitro; blocks both chemokine receptor- and antigen receptor-mediated Rac activation in lymphocytes, resulting in marked reduction of chemotactic response and T cell activation. |
---|---|
References | References 1. Nishikimi A, et al. Chem Biol. 2012 Apr 20;19(4):488-97. 2. Watanabe M, et al. J Immunol. 2014 Dec 1;193(11):5660-7. View Related Products by Target Small GTPase |
Density | 1.4±0.1 g/cm3 |
---|---|
Molecular Formula | C18H13ClN2O2 |
Molecular Weight | 324.761 |
Exact Mass | 324.066559 |
LogP | 3.35 |
Index of Refraction | 1.728 |
Hazard Codes | Xi |
---|